Compare CRBU & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBU | CFBK |
|---|---|---|
| Founded | 2011 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 167.9M |
| IPO Year | 2021 | 1998 |
| Metric | CRBU | CFBK |
|---|---|---|
| Price | $1.45 | $27.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 1.1M | 50.2K |
| Earning Date | 03-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ 2.49 |
| Revenue | $9,295,000.00 | ★ $50,724,000.00 |
| Revenue This Year | $0.22 | $39.98 |
| Revenue Next Year | $4.48 | $10.47 |
| P/E Ratio | ★ N/A | $11.22 |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $0.66 | $19.23 |
| 52 Week High | $3.54 | $28.21 |
| Indicator | CRBU | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 34.21 | 72.29 |
| Support Level | $1.52 | $26.71 |
| Resistance Level | $1.63 | $27.43 |
| Average True Range (ATR) | 0.08 | 0.70 |
| MACD | -0.00 | 0.19 |
| Stochastic Oscillator | 7.14 | 92.30 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.